PROMIS NEUROSCIENCES

promis-neurosciences-logo

ProMIS Neurosciences is a development-stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodegenerative diseases, in particular, Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS). It was founded in 2004 and headquartered in Toronto, Canada.
#SimilarOrganizations #People #Financial #Event #Website #More

PROMIS NEUROSCIENCES

Social Links:

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Diagnostics Medical Neuroscience Therapeutics

Founded:
2004-01-01

Address:
Toronto, Ontario, Canada

Country:
Canada

Website Url:
http://www.promisneurosciences.com

Total Employee:
1+

Status:
Active

Contact:
(416) 847-6898

Total Funding:
162.17 M USD

Technology used in webpage:
Euro Google Adsense Amazon Ireland Region


Similar Organizations

arctic-therapeutics-logo

Arctic Therapeutics

Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.

dimension-therapeutics-logo

Dimension Therapeutics

Dimension Therapeutics is a gene therapy company developing novel treatments for rare diseases.

eden-biologics-logo

Eden Biologics

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

prolocor-logo

Prolocor

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.

slingshot-biosciences-logo

Slingshot Biosciences

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

visterra-logo

Visterra

Visterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases.


Current Advisors List

mara-aspinall_image

Mara Aspinall Member of the Board of Advisory @ ProMIS Neurosciences
Advisor

richard-j-gregory_image

Richard J. Gregory Board Member @ ProMIS Neurosciences
Board_member
2017-07-01

not_available_image

Maggie Shafmaster Board of Directors @ ProMIS Neurosciences
Board_member
2021-10-01

neil-k-warma_image

Neil K. Warma Member Board Of Directors @ ProMIS Neurosciences
Board_member
2021-05-01

Current Employees Featured

elliot-goldstein_image

Elliot Goldstein
Elliot Goldstein President and CEO @ ProMIS Neurosciences
President and CEO
2015-07-01

daniel-geffken_image

Daniel Geffken
Daniel Geffken Chief Financial Officer @ ProMIS Neurosciences
Chief Financial Officer
2016-11-01

neil-cashman_image

Neil Cashman
Neil Cashman Chief Scientific Officer and Co-founder @ ProMIS Neurosciences
Chief Scientific Officer and Co-founder

eugene-williams_image

Eugene Williams
Eugene Williams Executive Chairman @ ProMIS Neurosciences
Executive Chairman
2015-07-01

not_available_image

Robert Gundel
Robert Gundel President and CEO @ ProMIS Neurosciences
President and CEO

larry-altstiel_image

Larry Altstiel
Larry Altstiel Chief Medical Officer @ ProMIS Neurosciences
Chief Medical Officer
2018-11-01

Founder


neil-cashman_image

Neil Cashman

Stock Details


Company's stock symbol is NASDAQ:PMN

Investors List

armistice-capital_image

Armistice Capital

Armistice Capital investment in Post-IPO Equity - ProMIS Neurosciences

great-point-partners_image

Great Point Partners

Great Point Partners investment in Post-IPO Equity - ProMIS Neurosciences

sphera-global-health-care-fund_image

Sphera Global Healthcare Fund

Sphera Global Healthcare Fund investment in Post-IPO Equity - ProMIS Neurosciences

ally-bridge-group_image

Ally Bridge Group

Ally Bridge Group investment in Post-IPO Equity - ProMIS Neurosciences

sphera-global-health-care-fund_image

Sphera Global Healthcare Fund

Sphera Global Healthcare Fund investment in Post-IPO Equity - ProMIS Neurosciences

affinity-asset-advisors_image

Affinity Asset Advisors

Affinity Asset Advisors investment in Post-IPO Equity - ProMIS Neurosciences

ally-bridge-group_image

Ally Bridge Group

Ally Bridge Group investment in Post-IPO Equity - ProMIS Neurosciences

Official Site Inspections

http://www.promisneurosciences.com Semrush global rank: 6.31 M Semrush visits lastest month: 1.05 K

  • Host name: ec2-174-129-30-187.compute-1.amazonaws.com
  • IP address: 174.129.30.187
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "ProMIS Neurosciences"

About :: ProMIS Neurosciences, Inc. (PMN)

Harnessing The Power of Selective Targeting of Toxic Oligomers to Combat Neurodegenerative Diseases and other Misfolded Protein Diseases. ProMIS Neurosciences is a clinical-stage biotechnology company committed to the …See details»

Management Team :: ProMIS Neurosciences, Inc. (PMN)

Larry Altstiel, M.D., Ph.D. brings decades of medical expertise in neurodegenerative diseases and experience in the pharmaceutical industry. At Pfizer, as vice president and head of …See details»

ProMIS Neurosciences - Crunchbase Company Profile & Funding

Contact Email kevin@promisneurosciences.com Phone Number (416) 847-6898 ProMIS Neurosciences is a development-stage biotech company that discovers and develops …See details»

ProMIS Neurosciences, Inc. (PMN) - Yahoo Finance Canada

See the company profile for ProMIS Neurosciences, Inc. (PMN) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»

ProMIS™ Neurosciences, Inc. | LinkedIn

ProMIS™ Neurosciences, Inc. CEO, Neil Warma, sat down with Precision AQ EVP & Managing Director, Hannah Deresiewicz, during the Precision AQ Corporate Access Event in San …See details»

ProMIS Neurosciences Company Profile | Management and

Smith@promisneurosciences.com: ProMIS Neurosciences Top Competitors. Company Employees Revenue Top technologies; AvantGen Inc. n/a: $2.9 M: Compass Therapeutics …See details»

ProMIS Neurosciences Inc. - CMOCRO

ProMIS Neurosciences, Inc., a development stage biotech company, discovers and develops precision medicine therapeutics for the treatment of neurodegenerative diseases, primarily …See details»

ProMIS Neurosciences Inc Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for ProMIS Neurosciences Inc of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»

ProMIS Neurosciences - Craft

Jul 21, 2023 ProMIS Neurosciences is a biotechnology company focused on discovering and developing antibody therapeutics selectively targeting toxic oligomers implicated in the …See details»

ProMIS Neurosciences 2025 Company Profile: Stock

ProMIS Neurosciences General Information Description. ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins …See details»

Investors :: ProMIS Neurosciences, Inc. (PMN)

Feb 25, 2025 Company Overview. ProMIS™ Neurosciences, Inc. (Nasdaq: PMN), is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics …See details»

ProMIS Neurosciences Inc - Company Profile - GlobalData

Website www.promisneurosciences.com Telephone 1 416 8476898. No of Employees 6. Industry Medical Equipment. Ticker Symbol & Exchange PMN (NASD) EPS XYZ. Net Income (2023) …See details»

ProMIS™ Neurosciences, Inc. | LinkedIn

ProMIS™ Neurosciences, Inc. CEO, Neil Warma, sat down with Precision AQ EVP & Managing Director, Hannah Deresiewicz, during the Precision AQ Corporate Access Event in San …See details»

ProMIS Neurosciences - Overview, News & Similar companies

Apr 9, 2024 ProMIS Neurosciences contact info: Phone number: (416) 847-6898 Website: www.promisneurosciences.com What does ProMIS Neurosciences do? ProMIS …See details»

ProMIS Neurosciences, Inc. Announces Leadership Transition

Jan 3, 2024 Visit us at www.promisneurosciences.com. Please submit media inquiries to info@promisneurosciences.com. For Investor Relations, please contact: Stern Investor …See details»

ProMIS Neurosciences to Present in Upcoming Investor …

Apr 4, 2024 A live webcast of the presentations may be accessed by visiting the Events page of the Company’s website at www.promisneurosciences.com, and will be available for at least 30 …See details»

ProMIS Neurosciences CEO Highlights Progress and Future Plans …

Jan 13, 2025 info@promisneurosciences.com. For Investor Relations, please contact: Precision AQ (formerly Stern IR) Anne Marie Fields, Managing Director …See details»

ProMIS Neurosciences Announces Full Year 2024 Financial Results …

Mar 31, 2025 "2024 was a transformational year for ProMIS Neurosciences as we reached a major milestone with the initiation of our 100-patient Phase 1b clinical trial for PMN310, our …See details»

ProMIS Neurosciences to Commence Trading on Nasdaq Under …

Jul 8, 2022 Visit us at www.promisneurosciences.com, follow us on Twitter and LinkedIn. For Investor Relations please contact: Alpine Equity Advisors Nicholas Rigopulos, President …See details»

ProMIS Neurosciences Announces Third Quarter 2021 Results

TORONTO and CAMBRIDGE, Mass., Nov. 12, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS or the Company”), a …See details»

linkstock.net © 2022. All rights reserved